Radiology

Your Article Summary

See Latest Articles

Excellent Local Control From Radiation Therapy for High-Risk Neuroblastoma
International Journal of Radiation Oncology*Biology*Physics, 08/13/09

Gatcombe HG et al. – Patients with high–risk neuroblastoma in series achieved excellent local control. Doses of 21–24 Gy to the primary tumor site appear to be adequate for local control for patients in the setting of minimal residual disease after induction chemotherapy and surgery. Patients with significant residual disease may benefit from radiation dose escalation, and this should be evaluated in a prospective clinical trial.

Today in Neuroradiology...keeping you current

Receive free subspecialty "5-minute updates" via email

Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy
European Journal of Neurology, 11/02/09

Imaging of Back Pain in Children
American Journal of Neuroradiology, 11/23/09

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
Journal of Clinical Oncology, 11/12/09

See All of Neuroradiology

Today in Radiotherapy (XRT)...keeping you current

Receive free subspecialty "5-minute updates" via email

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence
European Journal of Cancer, 11/05/09

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/11/09

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09

See All of Radiotherapy (XRT)